Superworth

West Pharmaceutical Services EV/EBIT WST

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Nov 3, 2026
35.9×
10-year median
34.8×
Against its 10-year history
56th
percentile: 0 is its lowest day, 100 its highest
10-year range
19.5× to 63.2×
Peer median
17.2×

West Pharmaceutical Services' EV/EBIT is 35.9× as of Nov 3, 2026.

That is above its ten-year median of 34.8×, close to the middle of its last ten years.

Over that time it ranged from 19.5× in Nov 2022 to 63.2× in Oct 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 17.2×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far35.9×27.3×39.5×
202532.6×25.3×43.1×
202441.6×34.4×45.1×
202338.6×21.1×44.5×
202221.4×19.5×42.7×
202150.1×43.0×59.7×
202055.0×31.5×63.2×
201937.5×29.4×38.2×
201829.0×27.1×37.3×
201732.6×24.1×34.8×
201627.4×24.4×40.9×
201534.3×20.5×36.5×
201422.4×17.4×23.4×
201322.8×15.3×24.0×
201215.1×13.4×17.2×
201115.5×14.7×19.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest West Pharmaceutical Services' size, closest first, today.

CompanyEV/EBIT
WSTWest Pharmaceutical Services35.9×
RMDResMed17.2×
MDLNMedlinen/m
BDXBecton, Dickinson and22.1×
SOLVSolventum8.3×
PENPenumbra65.2×
COOCooper Companies17.2×
ALGNAlign Technology16.2×
GMEDGlobus Medical15.9×
PODDInsulet21.0×
MSAMSA Safety18.4×
Peer median17.2×

Where West Pharmaceutical Services ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on West Pharmaceutical Services

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.